Effect of nociceptin/orphanin FQ on the rewarding properties of morphine

European Journal of Pharmacology

Volumn 404, Issue 1-2, 2000, Pages 153-159

  Ciccocioppo, Roberto ^a   Angeletti, Stefania ^a   Sanna, Pietro Paolo ^b   Weiss, Friedbert ^b   Massi, Maurizio ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Conditioned place preference; Locomotor sensitization; Morphine; Nociceptin; ORL1 receptor; Orphanin FQ; Spatial learning

Indexed keywords

MORPHINE; NOCICEPTIN; OPIOID RECEPTOR LIKE 1 REEPTOR; RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; AVERSION; DRUG ACTIVITY; LOCOMOTION; MALE; MORPHINE ADDICTION; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REWARD; SENSITIZATION;

ANIMALS; CONDITIONING (PSYCHOLOGY); DRUG INTERACTIONS; MALE; MORPHINE; MORPHINE DEPENDENCE; MOTOR ACTIVITY; OPIOID PEPTIDES; RATS; RATS, WISTAR; REWARD; SWIMMING; VASODILATOR AGENTS;

EID: 0034666649     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00590-2     Document Type: Article

References (47)

1. Acquas E., Carboni E., Leone P., Di Chiara G. SCH 23390 blocks drug-conditioned place preference and place aversion: anhedonia (lack of reward) or apathy (lack of motivation) after DA-receptor blockade? Psychopharmacology. 99:1989;151-155.
2. Agmo A., Belzung C. The role of subtypes of the opioid receptor in the anxiolytic action of chlordiazepoxide. Neuropharmacology. 37:1998;223-232.
3. Angeletti S., Panocka I., Ciccocioppo R., Gini L., Massi M. Effect of nociceptin (NC) on morphine-induced conditioned place preference (CPP) in rats. Regul. Pept. 80:1999;122.
4. Anton B., Fein J., To T., Li X., Silberstein L., Evans C.J. Immunohistochemical localization of ORL-1 in the central nervous system of the rat. J. Comp. Neurol. 368:1996;229-251.
5. Carlezon W.A. Jr., Rasmussen K., Nestler E.J. AMPA antagonist LY293558 blocks the development, without blocking the expression, of behavioral sensitization to morphine. Synapse. 31:1999;256-262.
6. Ciccocioppo R., Panocka I., Polidori C., Regoli D., Massi M. Effect of nociceptin on alcohol intake in alcohol-preferring rats. Psychopharmacology. 141:1999;220-224.
7. De Cabo de la Vega C., Pujol A., Paz Viveros M. Neonatally administered naltrexone affects several behavioral responses in adult rats of both genders. Pharmacol. Biochem. Behav. 50:1995;277-286.
8. Devine D.P., Reinscheid R.K., Monsma F.J. Jr., Civelli O., Akil H. The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion. Brain Res. 727:1996;225-229.
9. Di Chiara G. The role of DA in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend. 38:1995;95-137.
10. Di Giannuario A., Pierretti S., Catalani A., Loizzo A. Orphanin FQ reduces morphine-induced DA release in the nucleus accumbens: a microdialysis study in rats. Neurosci. Lett. 272:1999;183-186.
11. Dymshitz J., Lieblich I. Opiate reinforcement and naloxone aversion, as revealed by place preference paradigm, in two strains of rats. Psychopharmacology. 92:1987;473-477.
12. 3H]nociceptin binding sites from telencephalic to mesencephalic regions of the mouse brain. Neurosci. Lett. 230:1997;33-36.
13. Henderson G., McKnight A.T. The orphan opioid receptor and its endogenous ligand nociceptin/orphanin FQ. Trends Pharmacol. Sci. 18:1997;293-300.
14. Herz A. Opioid reward mechanisms: a key role in drug abuse? Can. J. Physiol. Pharmacol. 76:1998;252-258.
15. Horger B.A., Shelton K., Schenk S. Preexposure sensitizes rats to the rewarding effects of cocaine. Pharmacol. Biochem. Behav. 37:1990;707-711.
16. Houtani T., Nishi M., Takeshima H., Nukada T., Sugimoto T. Structure and regional distribution of nociceptin/orphanin FQ precursor. Biochem. Biophys. Res. Commun. 219:1996;714-719.
17. Ikeda K., Watanabe M., Ichikawa T., Kobayashi T., Yano R., Kumanishi T. Distribution of prepro-nociceptin/orphanin FQ mRNA and its receptor mRNA in developing and adult mouse central nervous systems. J. Comp. Neurol. 399:1998;139-151.
18. Koob G.F., Sanna P.P., Bloom F.E. Neuroscience of addiction. Neuron. 21:1998;467-476.
19. Lett B.T. Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacology. 98:1989;357-362.
20. Maldonado R., Saiardi A., Valverde O., Samad T.A., Roques B.P., Borrelli E. Absence of opiate rewarding effects in mice lacking DA D2 receptors. Nature. 388:1997;586-589.
21. Mamiya T., NoDA Y., Nishi M., Takeshima H., Nabeshima T. Nociceptin system plays a role in the memory retention: involvement of naloxone benzoylhydrazone binding sites. NeuroReport. 10:1999;1171-1175.
22. Manabe T., Noda Y., Mamiya T., Katagiri H., Houtani T., Nishi M., Noda T., Takahashi T., Sugimoto T., Nabeshima T., Takeshima H. Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors. Nature. 394:1998;577-581.
23. Martin-Fardon R., Ciccocioppo R., Massi M., Weiss F. Nociceptin prevents stress-induced ethanol- but not cocaine-seeking behavior in rats. NeuroReport. 11:2000;1939-1943.
24. Meunier J.C. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor. Eur. J. Pharmacol. 340:1997;1-15.
25. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J.L., Guillemot J.C., Ferrara P., Monsarrat B. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 377:1995;532-535.
26. Mogil J.S., Grisel J.E., Reinscheid R.K., Civelli O., Belknap J.K., Grandy D.K. Orphanin FQ is a functional anti-opioid peptide. Neuroscience. 75:1996;333-337.
27. Mogil J.S., Grisel J.E., Zhangs G., Belknap J.K., Grandy D.K. Functional antagonism of mu-, delta- and kappa-opioid antinociception by orphanin FQ. Neurosci. Lett. 214:1996;131-134.
28. Morgan M.M., Grisel J.E., Robbins C.S., Grandy D.K. Antinociception mediated by the periaqueductal gray is attenuated by orphanin FQ. NeuroReport. 8:1997;3431-3434.
29. Murphy N.P., Lee Y., Maidment N.T. Orphanin FQ/nociceptin blocks acquisition of morphine place preference. Brain Res. 832:1999;168-170.
30. Murphy N.P., Lee Y., Maidment N.T. Orphanin FQ/nociceptin modulation of mesolimbic DA transmission determined by microdialysis. J. Neurochem. 73:1999;179-186.
31. Neal C.R. Jr., Mansour A., Reinscheid R., Nothacker H.P., Civelli O., Watson S.J. Jr. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J. Comp. Neurol. 406:1999;503-547.
32. Nothacker H.P., Reinscheid R.K., Mansour A., Henningsen R.A., Ardati A., Monsma F.J. Jr., Watson S.J., Civelli O. Primary structure and tissue distribution of the orphanin FQ precursor. Proc. Natl. Acad. Sci. U. S. A. 93:1996;8677-8682.
33. Parker L.A., Rennie M. Naltrexone-induced aversions: assessment by place conditioning, taste reactivity, and taste avoidance paradigms. Pharmacol. Biochem. Behav. 41:1992;559-565.
34. Paxinos G., Watson C. The Rat Brain in Sterotaxic Coordinates. 2nd edn. 1986;Academic Press, North Ryde, NSW, Australia.
35. Polidori C., Calo' G., Ciccocioppo R., Guerrini R., Regoli D., Massi M. Pharmacological characterization of the nociceptin receptor mediating hyperphagia: identification of a selective antagonist. Psychopharmacology. 148:2000;230-237.
36. Pomonis J.D., Billington C.J., Levine A.S. Orphanin FQ, agonist of orphan opioid receptor ORL1, stimulates feeding in rats. NeuroReport. 8:1996;369-371.
37. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma F.J. Jr., Civelli O. Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor. Science. 270:1995;792-794.
38. Reinscheid R.K., Ardati A., Monsma F.J. Jr., Civelli O. Structure-activity relationship studies on the novel neuropeptide orphanin FQ. J. Biol. Chem. 271:1996;14163-14168.
39. Reinscheid R.K., Higelin J., Henningsen R.A., Monsma F.J. Jr., Civelli O. Structures that delineate orphanin FQ and dynorphin a pharmacological selectivities. J. Biol. Chem. 273:1998;1490-1495.
40. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18:1993;247-291.
41. Sandin J., Georgieva J., Schott P.A., Ogren S.O., Terenius L. Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats. Eur. J. Neurosci. 9:1997;194-197.
42. Shippenberg T.S., Bals-Kubik R., Herz A. Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic DA system and D-1 vs. D-2 DA receptors. J. Pharmacol. Exp. Ther. 265:1993;53-59.
43. 35S]guanylyl-5′-O-(gamma-thio)-triphosphate binding in guinea pig brain. J. Comp. Neurol. 386:1997;562-572.
44. Spanagel R., Herz A., Shippenberg T.S. The effects of opioid peptides on DA release in the nucleus accumbens: an in vivo microdialysis study. J. Neurochem. 55:1990;1734-1740.
45. Spanagel R., Weiss F. The DA hypothesis of reward: past and current status. Trends Neurosci. 2:1999;521-527.
46. Swerdlow N.R., Gilbert D., Koob G.F. Conditioned drug effects on spatial preference. Boulton A.A., Baker G.B., Greenshaw A.J. Neuromethods: 13, Psychopharmacology. 1989;399-446 Humana Press, Clifton, NJ.
47. Williams K.L., Woods J.H. Conditioned effects produced by naltrexone doses that reduce ethanol-reinforced responding in rhesus monkeys. Alcohol Clin. Exp. Res. 23:1999;708-715.